These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5122679)

  • 1. Substrate induced difference spectrum of microsomal P-450 in human liver.
    Kamataki T; Kitada M; Kitagawa H
    Chem Pharm Bull (Tokyo); 1971 Aug; 19(8):1749-50. PubMed ID: 5122679
    [No Abstract]   [Full Text] [Related]  

  • 2. Substrate-induced spectral change of liver microsomes in phenobarbital and methylcholanthrene-treated male and female rats.
    Kato R; Takanaka A; Takayanaghi M
    J Biochem; 1970 Sep; 68(3):395-413. PubMed ID: 5472352
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the relationship between the effects of various substances on absorption spectrum of cytochrome P-450 and the reduction of p-nitrobenzoate by mouse liver microsomes.
    Sasame HA; Gillette JR
    Mol Pharmacol; 1969 Mar; 5(2):123-30. PubMed ID: 4389182
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the rate of reduction of hepatic microsomal cytochrome P-450 by reduced nicotinamide adenine dinucleotide phosphate: effect of drug substrates.
    Gigon PL; Gram TE; Gillette JR
    Mol Pharmacol; 1969 Mar; 5(2):109-22. PubMed ID: 4389181
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between difference spectra and metabolism. Barbiturates, drug interaction and species difference.
    Topham JC
    Biochem Pharmacol; 1970 May; 19(5):1695-701. PubMed ID: 4398017
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the microsomal metabolism of 3 H-reserine.
    Stitzel RE; Wagner LA; Stawarz RJ
    J Pharmacol Exp Ther; 1972 Sep; 182(3):500-6. PubMed ID: 5055408
    [No Abstract]   [Full Text] [Related]  

  • 7. Decrease in the substrate interaction with cytochrome P-450 in drug hydroxylation by liver microsomes from rats bearing Walker 256 carcinosarcoma.
    Kato R; Takanaka A; Takahashi A
    Gan; 1970 Aug; 61(4):359-65. PubMed ID: 5454683
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of drug substrates on the reduction of hepatic microsomal cytochrome P-450 by NADPH.
    Gigon PL; Gram TE; Gillette JR
    Biochem Biophys Res Commun; 1968 May; 31(4):558-62. PubMed ID: 4385338
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of repeated exposure to aniline, nitrobenzene, and benzene on liver microsomal metabolism in the rat.
    Wiśniewska-Knypl JM; Jablońska JK; Piotrowski JK
    Br J Ind Med; 1975 Feb; 32(1):42-8. PubMed ID: 1125127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of various modifiers on rat microsomal peroxidase kinetics.
    Islam SI
    Biochem Pharmacol; 1982 May; 31(9):1823-6. PubMed ID: 7104049
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug metabolism and drug-induced spectral interactions in human fetal liver microsomes.
    Pelkonen O
    Biochem Pharmacol; 1973 Oct; 22(19):2357-64. PubMed ID: 4147669
    [No Abstract]   [Full Text] [Related]  

  • 12. The interactions of inducers, inhibitors, and substrates of drug-metabolizing enzymes with rat liver cytochrome P-450.
    Soliman MR; Johnson HD; Wade AE
    Drug Metab Dispos; 1974; 2(1):87-96. PubMed ID: 4150140
    [No Abstract]   [Full Text] [Related]  

  • 13. Spectral studies of the binding of O,O-diethyl p-nitrophenylphosphorothionate (parathion) to cytochrome P-450.
    Roth JA; Neal RA
    Biochemistry; 1972 Mar; 11(6):955-61. PubMed ID: 5013819
    [No Abstract]   [Full Text] [Related]  

  • 14. The binding of microsomal hydroxylation substrates to cytochrome P-450Rh and its effect on the nitrogen fixation by lupin bacteroids.
    Kretovich WL; Melik-Sarkissian SS; Raikchinstein MV; Archakov AI
    FEBS Lett; 1974 Aug; 44(3):305-8. PubMed ID: 4416102
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of morphine treatment and starvation on the substrate interaction with P-450 in the oxidation of drugs by liver microsomes.
    Kato R; Onoda K; Sasajima M
    Jpn J Pharmacol; 1970 Jun; 20(2):194-209. PubMed ID: 4393947
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of type I compounds on P-hydroxylation of aniline in vitro.
    Nakanishi S; Shioara E; Tsukada M; Kinoshita G
    Jpn J Pharmacol; 1972 Apr; 22(2):221-5. PubMed ID: 4538413
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of lipid peroxide decomposition by compounds which bind with cytochrome p-450.
    Islam SI; Zaher FA
    Life Sci; 1983 Sep; 33(12):1113-8. PubMed ID: 6888166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic experiments on the synergistic effect of NADH on microsomal drug oxidation.
    Netter KJ; Illing HP
    Xenobiotica; 1974 Sep; 4(9):549-61. PubMed ID: 4372813
    [No Abstract]   [Full Text] [Related]  

  • 19. The inhibition of bacterial bioluminescence by xenobiotics.
    Danilov VS; Ismailov AD; Baranova NA
    Xenobiotica; 1985 Apr; 15(4):271-6. PubMed ID: 4024661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activation of isophosphamide (NSC-109724), a new oxazaphosphorine, by rat liver microsomes.
    Allen LM; Creaven PJ
    Cancer Chemother Rep; 1972 Oct; 56(5):603-10. PubMed ID: 4405717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.